354 related items for PubMed ID: 30309995
1. Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil versus prednisone: protocol for a randomised, controlled, multicentre trial (INTENT study).
Ehren R, Benz MR, Doetsch J, Fichtner A, Gellermann J, Haffner D, Höcker B, Hoyer PF, Kästner B, Kemper MJ, Konrad M, Luntz S, Querfeld U, Sander A, Toenshoff B, Weber LT, Gesellschaft für Pädiatrische Nephrologie (GPN).
BMJ Open; 2018 Oct 10; 8(10):e024882. PubMed ID: 30309995
[Abstract] [Full Text] [Related]
2. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Hodson EM, Wong SC, Willis NS, Craig JC.
Cochrane Database Syst Rev; 2016 Oct 11; 10(10):CD003594. PubMed ID: 27726125
[Abstract] [Full Text] [Related]
3. [Mycophenolate mofetil versus cyclosporine A in children with primary refractory nephrotic syndrome].
Geng HY, Ji LN, Chen CY, Tu J, Li HR, Bao R, Lin Y.
Zhonghua Er Ke Za Zhi; 2018 Sep 02; 56(9):651-656. PubMed ID: 30180402
[Abstract] [Full Text] [Related]
4. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
Li X, Tian J, Wu J, He Q, Li H, Han F, Li Q, Chen Y, Ni Q, Chen J.
Clin Ther; 2009 Apr 02; 31(4):741-50. PubMed ID: 19446147
[Abstract] [Full Text] [Related]
5. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
[Abstract] [Full Text] [Related]
6. Randomised controlled trial comparing rituximab to mycophenolate mofetil in children and young adults with steroid-dependent idiopathic nephrotic syndrome: study protocol.
Lugani F, Angeletti A, Ravani P, Vivarelli M, Colucci M, Caridi G, Verrina E, Emma F, Ghiggeri GM.
BMJ Open; 2021 Nov 29; 11(11):e052450. PubMed ID: 34845071
[Abstract] [Full Text] [Related]
7. Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome.
Basu B, Preussler S, Sander A, Mahapatra TKS, Schaefer F.
BMC Nephrol; 2020 Nov 30; 21(1):520. PubMed ID: 33256621
[Abstract] [Full Text] [Related]
8. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y.
Pediatr Nephrol; 2015 Jul 30; 30(7):1121-9. PubMed ID: 25773534
[Abstract] [Full Text] [Related]
9. Mycophenolic Acid Pharmacokinetics and Relapse in Children with Steroid-Dependent Idiopathic Nephrotic Syndrome.
Tellier S, Dallocchio A, Guigonis V, Saint-Marcoux F, Llanas B, Ichay L, Bandin F, Godron A, Morin D, Brochard K, Gandia P, Bouchet S, Marquet P, Decramer S, Harambat J.
Clin J Am Soc Nephrol; 2016 Oct 07; 11(10):1777-1782. PubMed ID: 27445161
[Abstract] [Full Text] [Related]
10. Clinical observations of mycophenolate mofetil therapy in refractory primary nephrotic syndrome.
Zhao M, Chen X, Chen Y, Liu Z, Liu Y, Lu F, Zhang Y, Wang H.
Nephrology (Carlton); 2003 Jun 07; 8(3):105-9. PubMed ID: 15012724
[Abstract] [Full Text] [Related]
11. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
Kidney Int; 2017 Jul 07; 92(1):248-257. PubMed ID: 28318625
[Abstract] [Full Text] [Related]
12. Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome.
Dehoux L, Hogan J, Dossier C, Fila M, Niel O, Maisin A, Macher MA, Kwon T, Baudouin V, Deschênes G.
Pediatr Nephrol; 2016 Nov 07; 31(11):2095-101. PubMed ID: 27263020
[Abstract] [Full Text] [Related]
13. Prevention of relapses with levamisole as adjuvant therapy in children with a first episode of idiopathic nephrotic syndrome: study protocol for a double blind, randomised placebo-controlled trial (the LEARNS study).
Veltkamp F, Khan DH, Reefman C, Veissi S, van Oers HA, Levtchenko E, Mathôt RAA, Florquin S, van Wijk JAE, Schreuder MF, Haverman L, Bouts AHM.
BMJ Open; 2019 Aug 01; 9(8):e027011. PubMed ID: 31375606
[Abstract] [Full Text] [Related]
14. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
Przegl Lek; 2006 Aug 01; 63 Suppl 3():44-8. PubMed ID: 16898486
[Abstract] [Full Text] [Related]
15. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases.
Zhonghua Er Ke Za Zhi; 2014 Mar 01; 52(3):194-200. PubMed ID: 24824389
[Abstract] [Full Text] [Related]
16. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
Webb NJA, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Deeks JJ, Wheatley K, Ives NJ, PREDNOS Collaborative Group.
BMJ; 2019 May 23; 365():l1800. PubMed ID: 31335316
[Abstract] [Full Text] [Related]
17. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J.
Pediatr Nephrol; 2005 Jul 23; 20(7):914-9. PubMed ID: 15891923
[Abstract] [Full Text] [Related]
18. [Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children].
Ogarek I, Szczęsny-Choruz E, Wierzchowska-Słowiaczek E, Kwinta-Rybicka J, Stec Z, Moczulska A, Wilkosz K, Drożdż D.
Pol Merkur Lekarski; 2018 Apr 23; 44(262):192-195. PubMed ID: 29775447
[Abstract] [Full Text] [Related]
19. [Mycophenolate mofetil restores renal function and spares steroids during idiopathic nephrotic syndrome in children. A cohort study].
Cailliez M, Bruno D, Daniel L, Afaneti M, Bérard E, Sarles J, Tsimaratos M.
Nephrol Ther; 2008 Feb 23; 4(1):15-20. PubMed ID: 18096455
[Abstract] [Full Text] [Related]
20. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L.
Nephrology (Carlton); 2015 Jan 23; 20(1):18-24. PubMed ID: 25312783
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
